Anastrozole and Raloxifene Interaction

Compatible
Researched 90% confidence

Anastrozole and Raloxifene have a compatible interaction with 90% confidence. Raloxifene and anastrozole work through complementary mechanisms. Anastrozole reduces estrogen production via aromatase inhibition, while raloxifene blocks estrogen receptor signaling in breast tissue. Unlike tamoxifen, raloxifene is not metabolized via CYP pathways, so anastrozole does not impair its efficacy. Can be used together when both aromatase inhibition and breast tissue protection are desired. Both compounds affect the gonads and pituitary, so monitoring these systems is recommended.

Compound Profiles

Anastrozole

Aromatase Inhibitor | Estrogen Management

Anastrozole competitively binds to the heme group of the aromatase enzyme (cytochrome P450 19A1), reversibly inhibiting its catalytic activity. Aromatase is responsible for the final step in estrogen biosynthesis, converting testosterone to estradiol and androstenedione to estrone in peripheral tissues including adipose, muscle, liver, and brain.

Half-life: ~40-50 hours Typical dose: 0.25-0.5mg EOD or E3D (estrogen management) pct, anabolic
aromatase androgenicaromatase inhibitorestrogenichepatotoxic
View full profile

Raloxifene

Selective Estrogen Receptor Modulator | Gynecomastia & Bone Health

Raloxifene binds to both estrogen receptor alpha (ERalpha) and estrogen receptor beta (ERbeta), producing tissue-dependent agonist or antagonist effects determined by the local complement of coactivator and corepressor proteins. In breast tissue, raloxifene functions as a potent estrogen antagonist, blocking estradiol-mediated proliferative signaling with high selectivity.

Half-life: ~28 hours Typical dose: 60mg oral daily pct
estrogen receptor hepatotoxicpct agentteratogenic
View full profile

Combined Organ Load

Gonads
moderate
Liver
moderate
Heart
low
Pituitary
low

Shared Safety Flags

2x 2 hepatotoxic compounds (Anastrozole, Raloxifene). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 compounds share the pct-agent safety flag (Anastrozole, Raloxifene). Monitor accordingly.
2x 2 compounds share the teratogenic safety flag (Anastrozole, Raloxifene). Monitor accordingly.

Frequently Asked Questions

Can I take Anastrozole with Raloxifene?

Yes, Anastrozole and Raloxifene can generally be taken together. Raloxifene and anastrozole work through complementary mechanisms. Anastrozole reduces estrogen production via aromatase inhibition, while raloxifene blocks estrogen receptor signaling in breast tissue. Unlike tamoxifen, raloxifene is not metabolized via CYP pathways, so anastrozole does not impair its efficacy. Can be used together when both aromatase inhibition and breast tissue protection are desired.

Is Anastrozole and Raloxifene safe together?

Based on documented research, this combination is considered compatible. However, shared safety flags include: hepatotoxic, pct agent, teratogenic. Monitor accordingly.

What are the interactions between Anastrozole and Raloxifene?

Raloxifene and anastrozole work through complementary mechanisms. Anastrozole reduces estrogen production via aromatase inhibition, while raloxifene blocks estrogen receptor signaling in breast tissue. Unlike tamoxifen, raloxifene is not metabolized via CYP pathways, so anastrozole does not impair its efficacy. Can be used together when both aromatase inhibition and breast tissue protection are desired. This assessment has 90% confidence and is based on documented research data.

How should I time Anastrozole and Raloxifene?

Anastrozole has a half-life of ~40-50 hours and Raloxifene has a half-life of ~28 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Anastrozole vs Raloxifene

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.